Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney
Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney
复制标题
DOI:
10.1111/j.1476-5381.2011.01231.x
复制
发表时间:
2011-05-01
影响因子:
7.3
通讯作者:
Satoh, Keisuke
中科院分区:
文献类型:
--
作者:
Shimizu, Shogo;Saito, Motoaki;Satoh, Keisuke
BACKGROUND AND PURPOSENicorandil, an ATP-sensitive potassium (K-ATP) channel opener and nitric oxide donor, is used in the treatment of angina and acute heart failure. Here we investigated the effects of two K-ATP channel openers, nicorandil and cromakalim on ischaemia reperfusion (I-R) injury in the kidney.EXPERIMENTAL APPROACHRight nephrectomy was performed in 8-week-old male Sprague-Dawley rats and they were then divided into six groups: control group; I-R, including 30 min of left renal ischaemia followed by 24 h of reperfusion; I-R groups plus nicorandil 3 or 10 mg center dot kg-1 i.p.; and I-R groups plus cromakalim 100 or 300 mu g center dot kg-1 i.p. After reperfusion, renal function was estimated by serum creatinine (SCr), urinary albumin : creatinine ratio (ACR) and urinary beta 2-microglobulin (beta 2-MG). Levels of K-ATP channel subtypes were investigated by Western blot. Kidney sections were stained for 4-hydroxy-2-nonenal and 8-hydroxy-2'-deoxyguanosine.KEY RESULTSRenal I-R induced significant increases in SCr, ACR and beta 2-MG levels compared with the control animals. Treatment with K-ATP channel openers reduced urinary beta 2-MG levels, raised by I-R. Both K(IR)6.1 and K(IR)6.2 channels were expressed. Expression of K(IR)6.2 channels in the I-R group was lower than in the control group, which was restored to normal by treatment with K-ATP channel openers. Histologically, severe acute tubular damage was observed in the I-R kidney and this damage was ameliorated by K-ATP channel openers, dose-dependently.CONCLUSIONS AND IMPLICATIONSATP-sensitive potassium channel openers protected against proximal tubule damage after I-R injury. Nicorandil could represent a powerful additional component in the treatment of patients undergoing partial nephrectomy or renal transplantation.